Stocks Hitting 52-Week Highs


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Neurocrine Biosciences Inc. (NASDAQ: NBIX) shares reached a new 52-week high of $27.62 after

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

AbbVie Inc. (NYSE: ABBV), in cooperation with Neurocrine Biosciences, announced positive top-line results from Phase 3 study of investigational medicine elagolix. Impax Laboratories Inc. (NASDAQ: IPXL) shares touched a new 52-week high of $35 after the company reported the FDA approval of RYTARY ER-capsules for the treatment of parkinson's disease. Macy's, Inc. (NYSE: M) shares touched a new 52-week high of $67.96. Macy's PEG ratio is 1.19. Constellation Brands Inc. (NYSE: STZ) shares climbed 4.76% to reach a new 52-week high of $107.96 after the company reported upbeat earnings for the fiscal third quarter and raised its forecast for the full year.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: NewsIntraday UpdateMarketsMovers52 Week Highs52-Week HighsBiotechnologyConsumer DiscretionaryDepartment StoresHealth Care